ArticleMolecular biomedicine2026

Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy.

Yuning Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.